Celldex Payables Turnover from 2010 to 2024

CLDX Stock  USD 26.58  0.36  1.37%   
Celldex Therapeutics Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover will likely drop to 0.82 in 2024. Payables Turnover is a liquidity ratio that shows how quickly Celldex Therapeutics pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
0.86090441
Current Value
0.82
Quarterly Volatility
24.11036687
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Celldex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celldex Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 5.8 M or Selling General Administrative of 29.4 M, as well as many indicators such as Price To Sales Ratio of 293, Dividend Yield of 0.0 or PTB Ratio of 3.62. Celldex financial statements analysis is a perfect complement when working with Celldex Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Celldex Therapeutics Correlation against competitors.
For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.

Latest Celldex Therapeutics' Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Celldex Therapeutics over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Celldex Therapeutics' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celldex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Very volatile
   Payables Turnover   
       Timeline  

Celldex Payables Turnover Regression Statistics

Arithmetic Mean21.80
Geometric Mean7.07
Coefficient Of Variation110.58
Mean Deviation21.62
Median9.75
Standard Deviation24.11
Sample Variance581.31
Range61.7408
R-Value(0.03)
Mean Square Error625.39
R-Squared0
Significance0.91
Slope(0.17)
Total Sum of Squares8,138

Celldex Payables Turnover History

2024 0.82
2023 0.86
2022 0.42
2021 2.5
2020 40.59
2019 36.35
2018 62.16

About Celldex Therapeutics Financial Statements

Celldex Therapeutics investors use historical fundamental indicators, such as Celldex Therapeutics' Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Celldex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 0.86  0.82 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Celldex Stock Analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.